LIBRA, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 11.066
EU - Europa 5.312
AS - Asia 4.551
SA - Sud America 940
AF - Africa 525
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 13
Totale 22.425
Nazione #
US - Stati Uniti d'America 10.629
SG - Singapore 2.224
CN - Cina 1.700
IT - Italia 1.644
IE - Irlanda 1.313
UA - Ucraina 1.085
BR - Brasile 872
CA - Canada 386
RU - Federazione Russa 339
CI - Costa d'Avorio 294
DE - Germania 272
SN - Senegal 139
SE - Svezia 136
VN - Vietnam 112
IN - India 111
GB - Regno Unito 109
KR - Corea 92
FR - Francia 60
FI - Finlandia 58
CH - Svizzera 55
NL - Olanda 51
AT - Austria 40
BD - Bangladesh 39
UZ - Uzbekistan 37
HK - Hong Kong 34
IQ - Iraq 32
TR - Turchia 32
MX - Messico 31
ZA - Sudafrica 31
PL - Polonia 30
AR - Argentina 27
BE - Belgio 23
PK - Pakistan 23
ES - Italia 22
IR - Iran 22
NG - Nigeria 22
GR - Grecia 19
LB - Libano 14
EU - Europa 13
JP - Giappone 13
VE - Venezuela 13
AU - Australia 12
CZ - Repubblica Ceca 11
KE - Kenya 11
EC - Ecuador 10
BG - Bulgaria 9
JO - Giordania 7
KZ - Kazakistan 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
IL - Israele 6
NP - Nepal 6
TN - Tunisia 6
BH - Bahrain 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PE - Perù 5
RO - Romania 5
SA - Arabia Saudita 5
SI - Slovenia 5
CO - Colombia 4
ID - Indonesia 4
JM - Giamaica 4
KG - Kirghizistan 4
PH - Filippine 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
MT - Malta 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
HN - Honduras 2
LU - Lussemburgo 2
NO - Norvegia 2
RS - Serbia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BO - Bolivia 1
CU - Cuba 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
LV - Lettonia 1
NI - Nicaragua 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
Totale 22.425
Città #
Santa Clara 1.733
Chandler 1.371
Jacksonville 1.317
Dublin 1.304
Singapore 1.301
Chicago 585
Boardman 572
Catania 443
Cambridge 363
Lawrence 362
Andover 338
Nanjing 335
Hefei 304
Toronto 300
Abidjan 294
Des Moines 248
Ashburn 222
Beijing 214
Houston 192
San Mateo 154
Wilmington 143
Dakar 139
Grafing 133
The Dalles 121
Columbus 118
Council Bluffs 113
Nanchang 109
Los Angeles 107
Civitanova Marche 105
Seoul 92
Saint Petersburg 90
Shenyang 88
Hebei 87
Dong Ket 76
Palermo 70
Jiaxing 69
São Paulo 67
Ottawa 51
Falls Church 46
Tianjin 44
Seattle 42
Bremen 41
Messina 40
Rome 39
Changsha 37
Naples 36
Rio de Janeiro 36
Dallas 32
New York 31
Hong Kong 30
Helsinki 29
Munich 26
Guangzhou 25
Hanoi 25
Milan 25
Moscow 25
Belo Horizonte 24
Florence 24
Kunming 23
Mumbai 23
Abuja 22
Acireale 22
Brussels 22
Jinan 22
Padova 22
San Francisco 22
Augusta 21
Johannesburg 21
Leawood 21
Amsterdam 20
London 20
Mascalucia 20
Brooklyn 19
Ningbo 19
Lappeenranta 18
Norwalk 17
Warsaw 17
Baghdad 16
Ardabil 15
Boston 15
Redwood City 15
Zhengzhou 15
Dearborn 14
Aci Catena 13
Ann Arbor 13
Kochi 13
Mendicino 13
Vienna 13
Den Haag 12
Hangzhou 12
Liberty Lake 12
Maletto 12
Nuremberg 12
Tashkent 12
Chennai 11
Montreal 11
Porto Alegre 11
Stockholm 11
Tremestieri Etneo 11
Washington 11
Totale 15.071
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 308
Gut Microbiota and Cancer: From Pathogenesis to Therapy 200
Dietary intakes of carotenoids and other nutrients in the risk of nasopharyngeal carcinoma: a case-control study in Italy. 136
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021 115
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 112
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 111
Emerging Raf inhibitors 106
Absence of t(14;18) chromosome translocation in agricultural workers after short-term exposure to pesticides 105
Serum extracellular vesicle-derived circhipk3 and circsmarca5 are two novel diagnostic biomarkers for glioblastoma multiforme 104
Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant 104
Absence of BRAF gene mutation in non-melanoma skin tumors 103
Computational modelling in melanoma for novel drug discovery 100
Co-Occurrence of Interleukin-6 Receptor Asp358Ala Variant and High Plasma Levels of IL-6: An Evidence of IL-6 Trans-Signaling Activation in Deep Vein Thrombosis (DVT) Patients 98
Bovine seminal ribonuclease is cytotoxic for both malignant and normal telomerase-positive cells 97
MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma 96
Prognostic significance of deregulated microRNAs in uveal melanomas 96
B-Raf mutations are associated with a worse outcome in ovarian cancer 95
Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection 95
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 94
Benefits of using probiotics as adjuvants in anticancer therapy (Review) 94
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 93
Characterization of human melanoma cell lines and melanocytes by proteome analysis 93
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 93
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 93
Analysis of hepatitis C virus infection among health-care workers: an observational study 93
Analysis of the RAC1 mutations in cutaneous melanoma patients with occupational sun exposure 93
Droplet digital pcr analysis of liquid biopsy samples unveils the diagnostic role of hsa-mir-133a-3p and hsa-mir-375-3p in oral cancer 93
Ageing: from inflammation to cancer. 92
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 91
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 91
The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease 90
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 88
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 88
SERUM EXTRACELLULAR VESICLE-DERIVED CIRCHIPK3 AND CIRCSMARCA5 ARE TWO NOVEL DIAGNOSTIC BIOMARKERS FOR GLIOBLASTOMA MULTIFORME 88
Molecular screening in Sicilian families with hereditary non-poliposis colorectal cancer (H.N.P.C.C.) syndrome: identification of a novel mutation in MSH2 gene 87
Akt as a therapeutic target in cancer 87
Cutaneous melanoma: From pathogenesis to therapy 86
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer 86
Breast cancer risk in women treated with augmentation mammoplasty (Review) 85
Analysis of BRAF and PI3K mutations in melanoma from UV-exposed workers 85
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 85
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 84
DNA Damage and Apoptosis as In-Vitro Effect Biomarkers of Titanium Dioxide Nanoparticles (TiO2-NPs) and the Food Additive E171 Toxicity in Colon Cancer Cells: HCT-116 and Caco-2 83
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 83
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 83
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 83
Advances in targeting signal transduction pathways. 83
Associations of dietary carbohydrates, glycaemic index and glycaemic load with risk of bladder cancer: a case-control study. 83
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 83
Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer 83
Nitric Oxide in Hematological Cancers: Partner or Rival? 83
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? 83
microRNAs and thyroid cancer: Biological and clinical significance (Review). 82
MMP-9 as a marker-of response to treatment with B-Raf inhibitors in cutaneous melanoma 82
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 81
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development 81
Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines 80
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 80
Emerging MEK inhibitors 80
Analysis of BRAF mutation in primary and metastatic melanoma 79
Detection of BRAF gene mutation in primary choroidal melanoma tissue 78
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 78
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 78
Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy 78
Methylation‑sensitive restriction enzyme‑droplet digital PCR assay for the one‑step highly sensitive analysis of DNA methylation hotspots 77
B-cell neoplasia in the context of HCV infection: A distinct entity? 77
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 77
Emerging targeted therapies for melanoma treatment (review) 77
Vinflunine: still an option for patients with advanced urothelial carcinoma following immune-checkpoint inhibitors? [Vinflunina: ancora un’opzione per i pazienti con carcinoma uroteliale avanzato trattati con inibitori dei checkpoint immunitari?] 77
Esposizione in vitro di cellule U937 a dicromato di potassio: studio dell’apoptosi [Esposizione in vitro di cellule U937 a dicromato di potassio: studio dell’apoptosi] In vitro exposure of U937 cells to potassium dichromate: study of apoptosis 76
Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy 76
Analysis of the B-RafV600E mutation in cutaneous melanoma patients with occupational sun exposure 76
Droplet digital PCR for the detection and monitoring of Legionella pneumophila 76
Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model 75
The Effect of Dietary Polyphenols on Vascular Health and Hypertension: Current Evidence and Mechanisms of Action 75
T (14; 18) TRANSLOCATION: A POTENTIAL MARKER OF HIGH-GRADE TRANSFORMATION IN HCV-ASSOCIATED MALT LYMPHOMAS 74
Epigenetic alterations and occupational exposure to benzene, fbers, and heavy metals associated with tumor development (Review) 73
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 73
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer 73
Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection 72
Second primary lymphoma or recurrence: A dilemma solved by VDJ rearrangement analysis 72
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 72
A spindle cell variant of diffuse large B-cell lymphoma possesses genotypic and phenotypic markers characteristic of a germinal center B-cell origin 72
FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study 72
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 72
Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions 71
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 71
Induction of caspase - independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO 71
Gene expression in mouse spermatogenesis during ontogenesis 71
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 70
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DediCa): Design of a clinical trial. 70
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 70
Cancer management during covid‐19 pandemic: Is immune checkpoint inhibitors‐based immunotherapy harmful or beneficial? 70
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 70
Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment 70
Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain 69
Quantitative evaluation of partial deletions of the DAZ gene cluster 69
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer 69
Targeting cancer stem cells - Lancing their Achilles heel 69
SnapShot: Cancer chemotherapy 68
Totale 8.732
Categoria #
all - tutte 94.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.165 0 150 276 28 483 64 305 1 292 26 418 122
2021/20222.682 305 375 33 60 405 50 362 79 227 36 71 679
2022/20234.375 394 167 66 437 400 742 24 778 1.066 61 171 69
2023/20241.745 97 241 119 134 66 307 43 101 14 39 309 275
2024/20257.585 70 1.158 435 338 1.731 683 286 349 627 778 566 564
2025/20261.380 968 412 0 0 0 0 0 0 0 0 0 0
Totale 23.000